Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Anna Meo"'
Publikováno v:
Chinese clinical oncology. 11(4)
Hepatic epithelioid hemangioendothelioma (HEHE) is an uncommon vascular endothelial cell cancer involving the hepatic tissue with full malignant potential. HEHE diagnosis is challenging because blood tests and radiological findings are often non-path
Autor:
Nicola Frisina, Domenica Maisano, Nunziata Morabito, Anna Meo, Maria Plota, Agostino Gaudio, Antonino Lasco, Mariangela La Rosa, E. Morini, Fabio Franchina, Antonio Catalano, Giuseppina T. Russo, Adolfa Crifò
Publikováno v:
Bone. 40:1588-1594
Osteoporosis affects approximately 40-50% of adult patients with beta-Thalassemia Major (beta TM). Recent data have implicated an altered modulation of the osteoprotegerin (OPG)/receptor activator of NFkB ligand (RANKL) system in the pathogenesis of
Publikováno v:
Hemoglobin. 30:131-137
In this retrospective study, we report the results of the association of a combined phlebotomy program and chelation in hereditary sideroblastic anemia (HSA) to reduce iron overload after bone marrow transplantation (BMT). A male HSA patient, not res
Autor:
Angelo Perrotta, Luigi Esposito, Mara Ferrara, Sofia Maria Rosaria Matarese, Matteo Francese, Barbara Borrelli, Maria Angela La Rosa, Anna Meo
Publikováno v:
Hemoglobin. 27:167-175
Sixty‐seven homozygous male and female thalassemic patients with different phenotypes, aged between 8 and 33 years, were divided into three groups, according to the severity of their β‐thalassemia (thal) mutations. We investigated whether some c
Autor:
D. C. Salpietro, R. Caruso, Anna Meo, Luciana Rigoli, Ignazio Barberi, M. Ricca, K. Alessio, M. La Rosa, M.R. Miceli
Publikováno v:
Clinical & Laboratory Haematology. 23:373-378
The prevalence of eight mutations in 84 patients with beta-thalassaemia major and in 16 subjects with thalassaemia intermedia was investigated. All of the patients were Italian, originating from Eastern Sicily (Messina area) and some Calabrian region
Publikováno v:
Internal and Emergency Medicine. 5:83-85
Hepcidin, a 25 amino acid peptide expressed in the liver, has been shown to have a major role in iron homeostasis controlling iron release from reticuloendothelial and intestinal epithelial cells. Human hepcidin is encoded as a prohormone called pre-
Publikováno v:
Acta Haematologica. 119:15-17
Publikováno v:
European Journal of Haematology. 74:523-525
We studied a patient with mild beta-thalassaemia major under treatment with the oral chelator deferiprone (DFP or L1) for about 10 yr (L1 veteran). Due to poor compliance with desferrioxamine, the patient started compassionate use of DFP at an age of
Autor:
Michele Rizzo, Crocetta Argento, Angela Vitrano, Pietro Violi, R. Malizia, Domenico Giuseppe D'Ascola, Carmelo Magnano, Aurelio Maggio, Marcello Capra, Saveria Campisi, Francesco Cantella, Francesca Valeria Commendatore, Francesco Gagliardotto, Liana Cuccia, Giovanni Giugno, Rocca Cingari, Carmelo Fidone, Maria Antonietta Romeo, Paolo Rigano, Luciano Prossomariti, Anna Meo, Paolo Cianciulli, Gaetano Roccamo, Aldo Filosa, Maria Concetta Galati, Gaetano Giuffrida, Vincenzo Caruso, Turi Lombardo, Angela Ciancio, Calogera Gerardi
The prognosis for thalassemia major has dramatically improved in the last two decades. However, many transfusion-dependent patients continue to develop progressive accumulation of iron. This can lead to tissue damage and eventually death, particularl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c528499eeaa1c4acab63f412e90b29eb
http://hdl.handle.net/10447/62337
http://hdl.handle.net/10447/62337
Autor:
Nicola Frisina, Anastasia Xourafa, Nancy Morabito, Macrì I, Antonino Lasco, S Morgante, Agostino Gaudio, A. Trifiletti, Anna Meo
Publikováno v:
Scopus-Elsevier
Thalassemia major is a common cause of skeletal morbidity, as shown by the increased fracture risk in thalassemic patients. The etiology of this bone disease is multifactorial and culminates in a state of increased bone turnover with excessive bone r